Neometals Ltd
(NMT $0.54) Buy
Analyst
Date
Price Target
Trent Barnett
5th May 2021
$1.03/sh from $1.00/sh
Please see attached for full report.Secondary ‘mega trend’ assets are adding up to be meaningful
Investment Case
NMT is in JV to develop a LIB (“lithium-ion battery”) recycling business with an initial footprint in Europe. It is very advanced, with the demonstration scale plant due for commissioning in coming months. FID for subsequent commercial starter plant (20ktpa capacity) is early CY22. The potential growth is substantial, and industry tailwinds
(mega-trends) are extremely strong. NMT also has several secondary projects. The secondary European project is vanadium recovery from stockpiled steel slags in Finland and Sweden. A third project is the very large Australian Barrambie titanium/vanadium deposit, likely to be exported as a high margin concentrate. The longer-term projects are a lithium conversion facility to process Mt Marion offtake (current plan is India) and the Mt Edwards nickel & PGE early stage development/exploration.
Key Points
·As a reminder, we assume the LIB recycling facility capex (for 100%, NMT share is 50%) is A$140m and EBITDA of A$74m pa for 20tkpa of feedstock. The JV is targeting modular growth to 200ktpa;
·NMT has recently updated the market on the economics of its two vanadium assets;
·We view both as secondary, and our Buy recommendation has instead been based on the lithium battery recycling opportunity (higher NPV, much larger growth potential);
·In the current bull market for resources though, the vanadium assets have potential for meaningful value;
·We value the Vanadium Slag (59% NMT) opportunity at 7cps. This is significantly lower than the Company estimate of around 33cps, but we use a higher discount rate (12% versus 10%), and we use lower vanadium prices and higher costs. On spot prices (US$10/lb), our NPV12 increase to 30cps. Momentum in vanadium prices, plus current shortages suggest prices could continue to rise. Prices are still well below previous peaks;
·We value the Barrambie vanadium/ilmenite/iron opportunity (100% NMT) at 11cps. We assume A$175m capex (2.4Mtpa) and opex US$140/t and selling prices of US$165/t. Our assumptions err closer to tin / tantalum capex requirements (crush, mill, spiral, no flotation), but given the significantly higher feedstock grade, we hope we are drastically too high for our capex assumption. On our assumptions, Barrambie generates A$35m pa post tax free cash flow (100% basis). On spot prices (we estimate around US$265/t), our Barrambie NPV increases to 99cps (100% basis), or free cash flow of A$127m pa. We expect a partner to fund capex and earn an interest in the project;
·Separately, we are also watching with interest the Mt Edwards (Nickel in WA) project. The recent palladium grades were very interesting. If palladium is proven to exist in payable quantities the potential for a re-rating is high. For now, we only attribute a small nominal project value;
·Our NMT valuation is $1.02, of which over three quarters is the LIB recycling opportunity. On spot prices, our valuation increases to $1.53/sh and the non-core assets contribute over half our valuation;
·Consequently, the longer a bull market in resources continues, and the more NMT can de-risk the development assets, the more diversified the company will become, in our view;
·We maintain our Buy recommendation.
Estimated project contribution – Base Case
Source: Euroz Hartleys
Euroz Hartleys Limited declares that it has acted as underwriter to and/or arranged an equity issue in and/or provided corporate advice to Neometals Ltd during the last year. Euroz Hartleys Limited has received a fee for these services.
This analyst declares that he has a beneficial interest in NMT.
Neometals Ltd
Year end 30 June
Share Price
0.54
A$/sh
Price Target
1.03
A$/sh
Valuation (DCF)
1.02
A$/sh
WACC
12.0%
Terminal Growth
0%
Shares on issue
549
m, diluted
Market Capitalisation
295.0
A$m
Enterprise Value
227.5
A$m
Cash (31 Mar 21a)
67.5
A$m
Debt (31 Mar 21a)
-
A$m
Key Financials
2020a
2021f
2022f
Revenue (A$m)
0.0
0.0
0.0
EBITDA (A$m)
-16.0
-12.8
-10.2
EBITA (A$m)
-16.7
-18.2
-14.0
Reported NPAT (A$m)
-14.6
-16.7
-14.1
Normalised NPAT (A$m)
-11.1
-12.0
-10.2
Operating Cashflow (A$m)
-11.5
-11.4
-10.7
Capex (A$m)*
-8.7
-2.0
-41.1
Op. Free Cashflow (A$m)
-20.2
-13.3
-51.8
Revenue Growth (%)
nm
nm
nm
EBITDA Growth (%)
nm
nm
nm
Norm. NPAT Growth (%)
nm
nm
nm
Normalised EPS (Ac)
-2.0
-2.2
-1.9
Norm. EPS growth (%)
nm
nm
PER (x)
nm
nm
nm
EV:EBITDA (x)
nm
nm
nm
EV:EBIT (x)
nm
nm
nm
DPS (Ac)
2.0
0.0
0.0
Dividend Yield (%)
3.7%
0.0%
0.0%
Net Debt (A$m)
-75.8
-62.5
-10.6
Net Debt:Equity (%)
0%
nm
nm
Interest Cover (x)
0.0
nm
nm
Share Price Chart
- Forums
- ASX - By Stock
- NMT
- Ann: Vanadium Recovery Project - Outstanding PFS Results
Ann: Vanadium Recovery Project - Outstanding PFS Results, page-26
Featured News
Add NMT (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.9¢ |
Change
-0.005(5.32%) |
Mkt cap ! $69.24M |
Open | High | Low | Value | Volume |
9.2¢ | 9.2¢ | 8.9¢ | $138.0K | 1.534M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 354581 | 8.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.1¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 354581 | 0.089 |
6 | 341381 | 0.088 |
3 | 221482 | 0.087 |
2 | 103000 | 0.086 |
12 | 264575 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.091 | 100000 | 1 |
0.093 | 57000 | 1 |
0.094 | 315000 | 3 |
0.095 | 173629 | 1 |
0.096 | 210514 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
NMT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online